Cargando…
Attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patients
AIMS: A nationwide diabetic retinopathy (DR) screening program has been established in Denmark since 2013. We aimed to perform an evaluation of adherence to DR screenings and to examine whether non-adherence was correlated to DR progression. METHODS: The population consisted of a register-based coho...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519674/ https://www.ncbi.nlm.nih.gov/pubmed/35953626 http://dx.doi.org/10.1007/s00592-022-01946-4 |
_version_ | 1784799452589981696 |
---|---|
author | Thykjær, Anne Suhr Andersen, N. Bek, T. Heegaard, S. Hajari, J. Laugesen, C. S. Möller, S. Pedersen, F. N. Rosengaard, L. Schielke, K. C. Kawasaki, R. Højlund, K. Rubin, K. H. Stokholm, L. Grauslund, J. |
author_facet | Thykjær, Anne Suhr Andersen, N. Bek, T. Heegaard, S. Hajari, J. Laugesen, C. S. Möller, S. Pedersen, F. N. Rosengaard, L. Schielke, K. C. Kawasaki, R. Højlund, K. Rubin, K. H. Stokholm, L. Grauslund, J. |
author_sort | Thykjær, Anne Suhr |
collection | PubMed |
description | AIMS: A nationwide diabetic retinopathy (DR) screening program has been established in Denmark since 2013. We aimed to perform an evaluation of adherence to DR screenings and to examine whether non-adherence was correlated to DR progression. METHODS: The population consisted of a register-based cohort, who participated in the screening program from 2013 to 2018. We analyzed age, gender, marital status, DR level (International Clinical DR severity scale, none, mild-, moderate-, severe non-proliferative DR (NPDR) and proliferative DR (PDR)), comorbidities and socioeconomic factors. The attendance pattern of patients was grouped as either timely (no delays > 33%), delayed (delays > 33%) or one-time attendance (unexplained). RESULTS: We included 205,970 patients with 591,136 screenings. Rates of timely, delayed and one-time attendance were 53.0%, 35.5% and 11.5%, respectively. DR level at baseline was associated with delays (mild-, moderate-, severe NPDR and PDR) and one-time attendance (moderate-, severe NPDR and PDR) with relative risk ratios (RRR) of 1.68, 2.27, 3.14, 2.44 and 1.18, 2.07, 1.26, respectively (P < 0.05). Delays at previous screenings were associated with progression to severe NPDR or PDR (hazard ratio (HR) 2.27, 6.25 and 12.84 for 1, 2 and 3+ delays, respectively). Any given delay doubled the risk of progression (HR 2.28). CONCLUSIONS: In a national cohort of 205,970 patients, almost half of the patients attended DR screening later than scheduled or dropped out after first screening episode. This was, in particular, true for patients with any levels of DR at baseline. DR progression in patients with delayed attendance, increased with the number of missed appointments. |
format | Online Article Text |
id | pubmed-9519674 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Milan |
record_format | MEDLINE/PubMed |
spelling | pubmed-95196742022-09-30 Attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patients Thykjær, Anne Suhr Andersen, N. Bek, T. Heegaard, S. Hajari, J. Laugesen, C. S. Möller, S. Pedersen, F. N. Rosengaard, L. Schielke, K. C. Kawasaki, R. Højlund, K. Rubin, K. H. Stokholm, L. Grauslund, J. Acta Diabetol Original Article AIMS: A nationwide diabetic retinopathy (DR) screening program has been established in Denmark since 2013. We aimed to perform an evaluation of adherence to DR screenings and to examine whether non-adherence was correlated to DR progression. METHODS: The population consisted of a register-based cohort, who participated in the screening program from 2013 to 2018. We analyzed age, gender, marital status, DR level (International Clinical DR severity scale, none, mild-, moderate-, severe non-proliferative DR (NPDR) and proliferative DR (PDR)), comorbidities and socioeconomic factors. The attendance pattern of patients was grouped as either timely (no delays > 33%), delayed (delays > 33%) or one-time attendance (unexplained). RESULTS: We included 205,970 patients with 591,136 screenings. Rates of timely, delayed and one-time attendance were 53.0%, 35.5% and 11.5%, respectively. DR level at baseline was associated with delays (mild-, moderate-, severe NPDR and PDR) and one-time attendance (moderate-, severe NPDR and PDR) with relative risk ratios (RRR) of 1.68, 2.27, 3.14, 2.44 and 1.18, 2.07, 1.26, respectively (P < 0.05). Delays at previous screenings were associated with progression to severe NPDR or PDR (hazard ratio (HR) 2.27, 6.25 and 12.84 for 1, 2 and 3+ delays, respectively). Any given delay doubled the risk of progression (HR 2.28). CONCLUSIONS: In a national cohort of 205,970 patients, almost half of the patients attended DR screening later than scheduled or dropped out after first screening episode. This was, in particular, true for patients with any levels of DR at baseline. DR progression in patients with delayed attendance, increased with the number of missed appointments. Springer Milan 2022-08-12 2022 /pmc/articles/PMC9519674/ /pubmed/35953626 http://dx.doi.org/10.1007/s00592-022-01946-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Thykjær, Anne Suhr Andersen, N. Bek, T. Heegaard, S. Hajari, J. Laugesen, C. S. Möller, S. Pedersen, F. N. Rosengaard, L. Schielke, K. C. Kawasaki, R. Højlund, K. Rubin, K. H. Stokholm, L. Grauslund, J. Attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patients |
title | Attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patients |
title_full | Attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patients |
title_fullStr | Attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patients |
title_full_unstemmed | Attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patients |
title_short | Attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patients |
title_sort | attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519674/ https://www.ncbi.nlm.nih.gov/pubmed/35953626 http://dx.doi.org/10.1007/s00592-022-01946-4 |
work_keys_str_mv | AT thykjærannesuhr attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients AT andersenn attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients AT bekt attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients AT heegaards attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients AT hajarij attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients AT laugesencs attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients AT mollers attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients AT pedersenfn attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients AT rosengaardl attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients AT schielkekc attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients AT kawasakir attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients AT højlundk attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients AT rubinkh attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients AT stokholml attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients AT grauslundj attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients |